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Introduction
Maintaining the integrity of DNA during transactions such as 
transcription, replication, and repair is critical for preventing 
chromosomal  mutations,  deletions,  and  rearrangements  that 
may ultimately lead to cancer. Replication of the human ge-
nome is a highly complex process that enables the effective and 
accurate  duplication  of  genetic  information.  Most  crucially, 
DNA replication is tightly monitored to ensure that the genome 
is replicated just once per cell cycle and that replication is com-
plete before mitosis begins (Branzei and Foiani, 2010). Simi-
larly, cellular responses to DNA double-strand breaks (DSBs) 
are  highly  coordinated  and  involve  the  sensing  of  damaged 
DNA together with signaling to DNA repair, cell-cycle check-
point, and apoptotic machineries (Ciccia and Elledge, 2010).
The eukaryotic genome contains numerous natural im-
pediments to replication, including unusual DNA structures, 
DNA-binding proteins, highly transcribed DNA sequences, and 
slow replication zones (Branzei and Foiani, 2010). Chromo-
somal fragile sites, which are classified as either rare or common, 
are specific genomic loci that display gaps or breaks on meta-
phase chromosomes after partial inhibition of DNA synthesis 
(Durkin and Glover, 2007). The majority of common fragile 
sites are induced by treatment with low doses of aphidicolin 
(APH), an inhibitor of replicative polymerases, which suggests 
that they arise as a consequence of replication stress (Glover 
et al., 1984). Common fragile sites have received particular 
attention in recent years because they are sites of frequent 
deletions and other chromosome rearrangements in tumor cells 
(Durkin and Glover, 2007).
p53 binding protein 1 (53BP1) is an important compo-
nent of the DNA damage response (DDR) that localizes to 
microscopically visible foci at DSB sites (Schultz et al., 2000). 
Animals or cells lacking 53BP1 are hypersensitive to ionizing ra-
diation, and display DNA damage checkpoint defects and impaired 
DNA repair (Ward et al., 2003). 53BP1 also plays important roles 
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hromosomal  deletions  and  rearrangements  in 
tumors are often associated with common fragile 
sites, which are specific genomic loci prone to 
gaps and breaks in metaphase chromosomes. Common 
fragile sites appear to arise through incomplete DNA rep-
lication because they are induced after partial replication 
inhibition by agents such as aphidicolin. Here, we show 
that in G1 cells, large nuclear bodies arise that contain 
p53 binding protein 1 (53BP1), phosphorylated H2AX 
(H2AX), and mediator of DNA damage checkpoint 1 
(MDC1), as well as components of previously characterized 
OPT (Oct-1, PTF, transcription) domains. Notably, we find 
that incubating cells with low aphidicolin doses increases 
the incidence and number of 53BP1-OPT domains in 
G1 cells, and by chromatin immunoprecipitation and 
massively parallel sequencing analysis of H2AX, we dem-
onstrate that OPT domains are enriched at common fragile 
sites. These findings invoke a model wherein incomplete 
DNA synthesis during S phase leads to a DNA damage 
response and formation of 53BP1-OPT domains in the 
subsequent G1.
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Cyc A–negative cells contained such bodies (Fig. 1 B). Of the 
Cyc A–negative cells containing 53BP1 bodies, 87% contained 
one body, whereas 11% and 2% contained two and more than 
two bodies, respectively (Fig. 1 B). In parallel studies, we found 
that 53BP1 nuclear bodies also existed in a subset of quiescent 
primary  human  fibroblasts  (unpublished  data).  Collectively, 
these data revealed that large 53BP1 nuclear bodies occur pref-
erentially in G0 and G1 cells.
To further characterize the formation of 53BP1 nuclear 
bodies in G1, we used human U2OS cells stably expressing 
53BP1 fused to EGFP. Live cell imaging revealed that when 
53BP1 bodies arose, they did so almost immediately after a mi-
totic cell entered G1 phase, and that in most cases (>90%), the 
bodies arose in parallel within both daughter cells (Fig. 1 C). 
Furthermore, when we pulsed cells with 5-ethynyl-2-deoxy-
uridine (EdU) to mark sites of DNA replication, we observed that 
53BP1 bodies were invariably EdU negative (Fig. 1 D). In 
accordance with our other data, this analysis revealed that 
although no large 53BP1 bodies were present in S phase cells, 
smaller 53BP1 nuclear foci existed in a fraction of early S phase 
cells (14%) and mid S phase cells (3%) but were absent in late 
S phase cells (Fig. 1 D). Collectively, these findings suggested 
that 53BP1 nuclear bodies are either removed, or do not form 
effectively, in mid or late S phase cells. This conclusion was 
supported by live imaging studies of U2OS cells stably express-
ing EGFP-53BP1 and mRuby-PCNA, where we observed that 
large nuclear 53BP1 bodies present in G1 cells gradually dis-
appeared as S phase progression ensued (Fig. 1 E).
53BP1 is a component of OPT domains
To determine whether 53BP1 nuclear bodies are related to one 
of the various subnuclear bodies/domains that have been previ-
ously documented (Spector, 2006), we used antibodies specific 
for such domains to see whether they colocalized with 53BP1. 
Thus, by staining with an antibody against fibrillarin, we found 
that 53BP1 nuclear bodies did not reside in the nucleolus and 
that, in fact, 53BP1 nuclear staining was consistently excluded 
from the nucleolus (Fig. S1). In addition, we found that 53BP1 
bodies did not colocalize with Cajal bodies as detected by coilin 
staining. Furthermore, 53BP1 nuclear bodies were not compo-
nents  of  splicing  speckles  containing  the  SC-35  protein,   
although we did note that 53BP1 bodies frequently had SC-35 
staining adjacent to them (Fig. S1).
As 53BP1 nuclear bodies are quite large in size (2–3 µm) 
and are cell cycle regulated, we explored whether they might 
correspond to OPT domains that share similar size and cell   
cycle characteristics, and which contain the transcription fac-
tors Oct-1 and PTF (Pombo et al., 1998). Strikingly, we ob-
served that 53BP1 nuclear bodies colocalized with staining 
produced by antibodies against Oct-1 and two different subunits 
of PTF (PTF and PTF) in BJ fibroblasts (Fig. 2 A). Consistent 
with earlier work (Pombo et al., 1998), we also found that a 
PML body often resided at the periphery of, or was contained 
within, 53BP1 nuclear bodies (Fig. 2 A). In addition, similar 
colocalizations between 53BP1 and Oct-1, PTF, or PML were 
observed in U2OS cells (Fig. 2 B). Collectively, these results 
established that 53BP1 is a component of the previously described 
in class switch recombination at immunoglobulin loci (Manis   
et al., 2004; Ward et al., 2004; Reina-San-Martin et al., 2007). 
In addition, loss of 53BP1 leads to impaired distal V-DJ join-
ing (Difilippantonio et al., 2008). Furthermore, chromosome 
fusions of Trf2-uncapped telomeres by classical nonhomolo-
gous end-joining (NHEJ) require 53BP1 (Rai et al., 2010). 
Additionally, defects in distal joining of dysfunctional telomeres 
via NHEJ are seen in the absence of 53BP1 (Dimitrova et al., 
2008). Notably, recent work has shown that 53BP1 deficiency 
rescues phenotypes associated with BRCA1 dysfunction. Thus, 
depletion of 53BP1 rescues the proliferation defect observed 
in Brca1-null cells and the hypersensitivity of Brca1-null cells 
to cisplatin and mitomycin C (Bouwman et al., 2010). Loss of 
53BP1 also alleviates the hypersensitivity of Brca1 mutant cells 
to PARP inhibition and allows for processing of DNA ends to 
promote homologous recombination (Bunting et al., 2010).
Here, we investigate the accumulation of 53BP1 in large 
nuclear bodies within a subset of asynchronously growing 
mammalian cells. Specifically, we reveal that these bodies rep-
resent previously characterized OPT (Oct-1, PTF, transcription) 
domains (Pombo et al., 1998), as 53BP1 colocalizes in these 
structures together with Oct-1 and PTF in G1 cells. In addition 
to showing that 53BP1-OPT domains represent sites of low 
transcriptional activity, we establish that their integrity depends 
on H2AX and the protein kinase activity of ataxia telangiectasia 
mutated (ATM). Consistent with these data, we demonstrate 
that 53BP1-OPT domains also contain phosphorylated H2AX 
(H2AX) and mediator of DNA damage checkpoint 1 (MDC1), 
which strongly suggests that these domains represent sites of 
DNA damage. Finally, we establish that although 53BP1-OPT 
domains are restricted to G1 cells, their formation is enhanced 
by exposure of cells to APH. We discuss these findings in rela-
tion to the molecular events leading to OPT domain formation 
and disassembly, as well as their potential functions in main-
taining genome integrity.
Results
53BP1 accumulates in nuclear bodies in 
G1 cells
Although it is well established that 53BP1 localizes to sites of 
DNA DSBs generated when cells are treated with DNA damag-
ing agents, we and others have known for several years (Morales 
et al., 2003; Doil et al., 2009) that 53BP1 localizes to a small 
number of large (2–3 µm) discrete bodies/foci in the nuclei of 
tissue culture cells grown under normal conditions (Fig. 1 A).   
Because these bodies occur in only a subset of cells within 
an asynchronously growing population, we explored whether 
53BP1  body  formation  was  cell  cycle  dependent.  Thus,  we 
performed immunofluorescence studies in several human and 
murine cell lines with an antibody against Cyclin A (Cyc A) 
as a marker of S/G2 phases. Strikingly, the large majority of 
cells containing large 53BP1 nuclear bodies were Cyc A nega-
tive (Fig. 1 A and not depicted). Furthermore, quantification 
of Cyc A–negative cells with large 53BP1 bodies in telomer-
ized (human telomerase reverse transcriptase [hTERT]) human   
BJ  fibroblasts  revealed  that  16%  of  total  cells  and  21%  of   99 Replication stress induces 53BP1-OPT domains in G1 • Harrigan et al.
53BP1-OPT domains require DNA  
damage signaling and exhibit low 
transcription levels
Previous work has established that DNA DSBs trigger acti-
vation of the phosphoinositide 3-kinase–related protein ki-
nases (PIKKs) ATM, ATR, and DNA-PK (Lempiäinen and 
OPT domain. While surveying for additional colocalizing fac-
tors, we found that the DEAD box RNA/RNA and RNA/DNA 
helicase  DDX1  also  localized  with  53BP1  nuclear  bodies 
(Fig. 2 C), showing that previously characterized DDX1 bodies 
(Li et al., 2006) in G1 cells are also components of 53BP1-
OPT domains.
Figure 1.  53BP1 accumulates in nuclear bodies   
in  a  subset  of  G1  cells.  (A)  Asynchronously 
growing BJ hTERT cells were fixed, and immuno-
fluorescence was performed with mouse anti-
53BP1  and  rabbit  anti–Cyc  A  antibodies. 
(B, left) Quantitation of total or Cyc A–negative 
cells  from  A  that  contained  53BP1  nuclear 
bodies. Results represent the mean ± SD from 
three  experiments  (total,  n  =  4,944;  Cyc  A 
negative, n = 3,956). (B, right) Quantitation 
of Cyc A–negative cells from A that contained 
53BP1 bodies. Results represent the mean ± 
SD from three experiments (n = 829). We note 
that 53BP1 foci were also observed in 10.8% 
(±2.8%) of Cyc A–positive cells (not depicted), 
which  likely  represent  early-to-mid  S  phase 
cells (see D). (C) Live cell imaging of U2OS 
cells stably expressing EGFP-53BP1 from mi-
tosis into G1. (D) BJ hTERT cells were pulsed 
with EdU for 10 min, fixed, and stained with 
rabbit anti-53BP1 antibodies. EdU was visual-
ized using click chemistry. (E) Live cell imaging 
of U2OS cells stably expressing EGFP-53BP1 
and  mRuby-PCNA  from  G1  into  S  phase.   
Bars: (A and C) 30 µm; (D and E) 10 µm.JCB • VOLUME 193 • NUMBER 1 • 2011   100
Halazonetis, 2009; Lovejoy and Cortez, 2009), which then 
phosphorylate various proteins, including the histone variant 
H2AX. H2AX then recruits MDC1, which is required for the 
effective accumulation and retention of 53BP1 at DSB sites 
(Celeste et al., 2003; Stucki and Jackson, 2006). Notably, we 
found that 53BP1-OPT domains colocalized with both H2AX 
and MDC1 (Fig. 3 A), which strongly suggests that they corre-
spond to sites of DNA damage. In accord with this, the propor-
tion of cells with 53BP1 nuclear bodies in Cyc A–negative cells 
was substantially lower in H2AX
/ mouse embryonic fibro-
blasts (MEFs) than in wild-type controls (Fig. 3 B). In addition, 
we found that 53BP1 nuclear bodies, as detected by 53BP1 
staining (Fig. 3 C) or staining with other OPT domain compo-
nents (PTF and PML; Fig. 3 D), were largely abrogated when 
asynchronously growing BJ cell populations were incubated 
with the ATM inhibitor KU-55933 (Hickson et al., 2004). In 
contrast, we found that 53BP1 formed large nuclear bodies 
that colocalized with PTF and PML within Cyc A–negative 
ATR-deficient Seckel cells (Fig. S2). However, we note that 
immunofluorescence studies revealed the presence of OPT   
domains, albeit smaller in size, in both ATM-deficient AT cells 
and ATM
/ MEFs (unpublished data), which suggests that, 
although OPT domain formation is largely ATM dependent, other 
PIKKs such as DNA-PK and/or ATR are also likely to contrib-
ute, particularly when ATM is absent. Collectively, these data 
strongly suggested that 53BP1-OPT domains represent sites of 
endogenously arising DNA damage in G1 cells. In line with this 
idea, we found that Oct-1, PTF, and PTF were recruited to 
tracts of DNA damage produced by laser micro-irradiation 
(Fig. S3 A). PTF also formed foci that colocalized with 53BP1 
in cells treated with ionizing radiation (Fig. 2 D), whereas PML 
did not (Fig. S3 B). These results thus provided additional sup-
port for OPT domains being sites of DNA damage and sug-
gested roles for various OPT domain components in the DDR.
Recent work has shown that transcription is inhibited at 
DNA DSB sites by mechanisms requiring ATM kinase activity 
(Shanbhag et al., 2010). Consistent with 53BP1-OPT domains 
in G1 cells corresponding to DNA damage sites, they did not 
colocalize with initiating or elongating forms of RNA polymerase II 
(Pol II), as detected by antibodies recognizing phosphorylated 
Figure 2.  53BP1 colocalizes with components 
of OPT domains. (A) Immunofluorescence was 
performed  in  BJ  primary  or  BJ  hTERT  (PTF) 
fibroblasts with mouse anti-53BP1 and rabbit 
anti–Oct-1, anti-PTF, or anti-PTF, and rabbit 
anti-53BP1  and  mouse  anti-PML  antibodies 
as indicated. Analysis of >100 cells revealed 
that 88% of 53BP1 nuclear bodies contained 
at least one PML body. (B) Experiments were 
performed as in A with U2OS cells and the 
indicated antibodies. (C) Immunofluorescence 
was performed in BJ primary fibroblasts with 
mouse anti-53BP1 and rabbit anti-DDX1 anti-
bodies. (D) BJ hTERT fibroblasts were exposed 
to 1.5 Gy of ionizing radiation and fixed 1 h   
later. Immunofluorescence was performed with 
rabbit  anti-PTF  and  mouse  anti-53BP1  anti-
bodies. Bars, 10 µm.101 Replication stress induces 53BP1-OPT domains in G1 • Harrigan et al.
we performed DNA immuno-FISH experiments. By using 
whole chromosome paints specific for seven different chromo-
somes, we found that 53BP1-OPT domains colocalized with 
chromosome 2 in 45% of cells with these domains (Fig. 5 A 
and Table I). These data were therefore consistent with a pre-
vious study by Pombo et al., (1998), which showed that PTF 
domains displayed the highest level of colocalization with chro-
mosome 2. Furthermore, our analyses revealed that >30% of 
cells containing 53BP1-OPT domains colocalized with chromo-
somes 3, 6, or 7 (Fig. 5 A and Table I).
To more precisely map the genomic regions containing 
OPT domains, we performed chromatin immunoprecipitation 
experiments followed by massively parallel sequencing (ChIP-seq; 
Robertson et al., 2007). Because we have observed that the 
majority of 53BP1 is chromatin bound (resistant to extraction 
Ser-5 (pS5) and Ser-2 (pS2) within the C-terminal domain of 
the Pol II large subunit (Fig. 4 A). Moreover, when we used in-
corporation of 5-fluorouridine (FlU) to detect sites of active 
transcription,  this  revealed  that  53BP1-OPT  domains  were 
largely devoid of FIU staining (Fig. 4 B). In addition, we ob-
served that 53BP1 nuclear bodies were lost when cells were 
treated with DNase I but not RNase A before immunofluores-
cence staining (Fig. 4 C and not depicted). Collectively, these 
results demonstrated that 53BP1-OPT domains associate with 
DNA but do not correspond to sites of detectable transcription.
Links between 53BP1-OPT domains and 
chromosomal fragile sites
To determine whether OPT domains containing 53BP1 are 
preferentially associated with particular chromosomal regions,   
Figure 3.  53BP1-OPT domains represent sites 
of DNA damage. (A) Immunofluorescence was 
performed  in  BJ  hTERT  fibroblasts  with  rab-
bit  anti-53BP1  and  mouse  anti-H2AX  (top) 
or  mouse  anti-53BP1  and  rabbit  anti-MDC1 
pSDTD  (bottom)  antibodies.  (B,  left)  Immuno-
fluorescence  was  performed  in  H2AX
+/+  or 
H2AX
/ MEFs with rabbit anti-53BP1 or mouse 
anti–Cyc A antibodies. (B, right) Quantitation 
of Cyc A–negative cells that contained 53BP1 
nuclear bodies. Results represent the mean ± SD 
from  three  experiments  (H2AX
+/+,  n  =  636; 
H2AX
/, n = 384). (C, left) BJ hTERT fibro-
blasts were incubated in the absence (Cont) or 
presence  of  ATM  inhibitor  KU55933  (ATMi; 
20  µM)  for  3  h.  Immunofluorescence  was 
performed with mouse anti-53BP1 and rabbit 
anti–Cyc A antibodies. (C, right) Quantitation 
of Cyc A–negative cells that contained 53BP1 
nuclear bodies. Results represent the mean ± SD   
from three experiments (Cont, n = 522; ATMi, 
n = 491). (D) Experiments were performed as 
in C and immunofluorescence was performed 
with  rabbit  anti-PTF  and  mouse  anti-53BP1 
antibodies (left) or mouse anti-PML and rabbit 
anti-53BP1 antibodies (right). Bars: (A) 10 µm; 
(B–D) 30 µm.JCB • VOLUME 193 • NUMBER 1 • 2011   102
with 400 mM salt) even when cells are grown in the absence of 
DNA damaging agents (unpublished data) and because cells 
containing OPT domains only represent a minority (16%) of 
the total cell population, we reasoned that ChIP-seq analysis of 
53BP1 itself would not be OPT domain specific. Therefore, we 
performed experiments on serum-starved BJ hTERT fibroblasts 
with antibodies against H2AX, as this phospho-epitope is 
highly specific to OPT domains in G0 cells that have not been 
treated with a DNA damaging agent. By comparing data sets 
derived from immunoprecipitated H2AX samples with those 
from control immunoglobulin immunoprecipitations, we found 
that H2AX was specifically associated with various specific 
regions of the genome in G0 arrested cells (Fig. 5 and Table II). 
The  genomic  locations  of  the  top  eight  H2AX-association 
peaks (as determined by fold enrichment) were located on chro-
mosomes 1 (1q23.2), 2 (2p24.2), 7 (7p13, 7q22.3), 9 (9q33.3), 
19 (19p13.3), 20 (20q13.33), and 21 (21q22.3), with four of 
these  peaks  corresponding  to  known  common  fragile  sites 
(FRA2C, FRA7D, FRA7F, and FRA19B; Schwartz et al., 2006; 
Durkin  and  Glover,  2007).  Collectively,  the  DNA  immuno-
FISH and ChIP-seq results therefore indicated enhanced associ-
ations of OPT domains with chromosomes 2 and 7 in human 
fibroblasts and, moreover, suggested that these domains prefer-
entially localize to chromosomal fragile sites.
Chromosomal fragile sites are induced by treating cells 
with low doses of APH, whereas other replication-inhibiting 
drugs such as hydroxyurea (HU) are less specific at inducing 
common fragile site lesions (Durkin and Glover, 2007). Thus, 
we hypothesized that DNA damage arising from unreplicated or 
partially replicated genomic regions might be responsible for 
the formation of 53BP1-OPT domains in G1 cells. Consistent 
with this, incubation of cells for 24 h with a low concentration 
of APH (0.4 µM) produced a marked increase in both the pro-
portion of Cyc A–negative cells containing 53BP1 nuclear bodies 
Figure 4.  53BP1-OPT domains do not associ-
ate with regions of active transcription and are 
dependent on DNA.  (A)  Immunofluorescence 
was performed in BJ primary fibroblasts with 
mouse anti-53BP1 and rabbit anti-Pol II pS2 
(top) or rabbit anti-53BP1 and mouse anti-Pol II   
pS5 (bottom) antibodies. (B) BJ primary fibro-
blasts  were  incubated  for  60  min  with  FlU 
and immunofluorescence was performed with 
rabbit anti-53BP1 and mouse anti-BrdU anti-
bodies. (C) BJ primary fibroblasts were incu-
bated in the absence or presence of DNase I 
as indicated for 10 min. Immunofluorescence 
was performed with rabbit anti-53BP1 or mouse 
anti–Lamin A/C antibodies. DAPI and Lamin 
A/C were positive and negative controls, re-
spectively. Bars, 10 µm.103 Replication stress induces 53BP1-OPT domains in G1 • Harrigan et al.
Figure 5.  H2AX accumulates at discrete regions of the genome in untreated cells. (A) DNA Immuno-FISH was performed in BJ hTERT fibroblasts with 
anti-53BP1 antibodies and whole chromosome paints. (A, left) Colocalization between 53BP1 nuclear bodies and chromosome regions. (A, right) No 
colocalization between 53BP1 nuclear bodies and chromosome regions. Bar, 10 µm. (B) ChIP-seq experiments were performed with serum-starved (G0) 
BJ hTERT fibroblasts and H2AX antibodies. The eight highest peaks for H2AX enrichment are displayed along with the negative control (IgG). Data are 
shown as custom tracks (bin 20) on the UCSC genome browser (data correspond to the Feb. 2009 GRCh37/hg19 genome assembly). The axis scales are 
presented on the left and chromosome position at the top.JCB • VOLUME 193 • NUMBER 1 • 2011   104
53BP1-OPT domains as a percentage of total cells, or the num-
ber of these domains per cell. However, a slightly increased pro-
portion of Cyc A–negative cells displaying 53BP1-OPT domains 
was observed after HU treatment (Fig. 6 C). Importantly, the 
differences observed between APH and HU did not reflect dif-
ferences in the extent of S phase perturbation, as both agents 
caused a similar accumulation of cells in S/G2 phase (from 27% 
in control cells to 46% and 52% in APH- and HU-treated cells, 
respectively), as determined by flow cytometry (Fig. 6 D). Further-
more, as shown in Fig. 6 E, incubation with either agent resulted 
and the number of these bodies per cell (Fig. 6, A and B). We 
note that under these conditions, 8% of Cyc A–positive cells 
also contained 53BP1 foci. Low APH doses also increased the 
number of PTF domains, which colocalized with 53PB1, as 
well as an increased association of 53BP1 with PML bodies 
(Fig. S4). Treatment of cells with a higher dose of APH (4 µM) 
produced similar results (unpublished data), although the ensuing 
numbers of 53BP1 nuclear bodies per cell were even higher.
In contrast to our observations after APH treatment, incu-
bation with HU did not significantly affect the incidence of 
Table I.  Frequency of association between chromosomes and 53BP1-OPT domains
Chromosome number Chromosome size Colocalization with 53BP1-OPT domains No colocalization with 53BP1-OPT domains
Mb % %
2 243 45 (n = 168) 55 (n = 203)
3 198 41 (n = 129) 59 (n = 188)
6 171 32 (n = 113) 68 (n = 241)
7 159 36 (n = 105) 64 (n = 194)
14 107 26 (n = 79) 74 (n = 235)
16 90 27 (n = 99) 73 (n = 261)
17 81 24 (n = 81) 76 (n = 254)
Results represent the average of two independent experiments. n = number of cells analyzed.
Table II.  ChIP-seq peaks for H2AX
Chromosome number Start position End position Chromosome position Fragile site
1 79171862 79172697 1p31.1
1 160068001 160069262 1q23.2
1 180991672 180992627 1q25.3 FRA1G
2 17699186 17700299 2p24.2 FRA2C
2 196527371 196527999 2q32.3
2 242823452 242824274 2q37.3 FRA2J
4 155337857 155338768 4q31.3
5 54095885 54096590 5q11.2
5 148822299 148823429 5q32
6 37137202 37138474 6p21.2
7 6542950 6544002 7p22.1 FRA7B
7 43622016 43623713 7p13 FRA7D
7 105751952 105753887 7q22.3 FRA7F
8 143858334 143859358 8q24.3 FRA8D
9 129986095 129988041 9q33.3
10 99599623 99600560 10q24.2
11 133906686 133907757 11q25
12 117565420 117567081 12q24.22
16 2954968 2956441 16p13.3
16 22201426 22202642 16p12.2
17 15163610 15165033 17p12 FRA17A
17 17109369 17110420 17p11.2
17 70404690 70406426 17q24.3
17 73829429 73831182 17q25.1
17 75276722 75278117 17q25.2
19 1122785 1123630 19p13.3 FRA19B
19 4327867 4329218 19p13.3 FRA19B
19 53030425 53031358 19q13.4
20 61424927 61426403 20q13.33
20 62272821 62273976 20q13.33
21 46824896 46826026 21q22.3
22 45636492 45637492 22q13.31 FRA22A105 Replication stress induces 53BP1-OPT domains in G1 • Harrigan et al.
Figure 6.  Replication perturbation by APH pro-
motes formation of 53BP1-OPT domains. (A) BJ 
hTERT fibroblasts were incubated in the absence 
(Cont) or presence of APH (0.4 µM, 24 h) as 
indicated.  Immunofluorescence  was  performed 
using mouse anti-53BP1 and rabbit anti–Cyc A 
antibodies. Bar, 30 µm. (B, left) Quantitation of 
total or Cyc A–negative cells from A that con-
tained 53BP1 nuclear bodies. Results represent 
the  mean  ±  SD  from  three  experiments  (total: 
Cont, n = 1,329; APH, n = 1,291; Cyc A nega-
tive: Cont, n = 987; APH, n = 843). (B, right) 
Quantitation  of  Cyc  A–negative  cells  from  A 
that  contained  53BP1  nuclear  bodies.  Results 
represent the mean ± SD from three experiments 
(Cont, n = 199; APH, n = 328). (C) BJ hTERT 
fibroblasts were incubated in the absence (Cont)   
or presence of HU for 24 h as indicated. Immuno-
fluorescence was performed as described in A and 
quantified as in B. Results represent the mean ± 
SD  from  three  experiments.  (D)  FACS  analysis 
of cells incubated in the absence or presence of 
APH or HU as indicated. (E) Cellular lysates from 
cells treated with APH or HU as in A and C were 
separated by SDS-PAGE, and Western blotting 
was performed with antibodies against FANCD2 
and PARP-1 (loading control).JCB • VOLUME 193 • NUMBER 1 • 2011   106
the  unreplicated  DNA  intermediate  would  be  recognized   
as DNA damage, resulting in the establishment of 53BP1-
OPT domains.
Although the above model suggests that the OPT domains 
would contain large stretches of single-stranded DNA (ssDNA), 
we note that we have not been able to detect the presence of 
ssDNA in 53BP1-OPT domains by immunofluorescence stain-
ing for RPA or for BrdU incorporation under nondenaturing 
conditions (Sartori et al., 2007; unpublished data). Thus, if 
ssDNA does exist in 53BP1-OPT domains, it must either be 
bound by proteins that we have not yet examined and/or must 
adopt secondary structures that preclude ssDNA detection.   
In this regard, we note that the ssDNA overhang of telomeres is 
bound by protein components of the Shelterin complex and is 
sequestered by the formation of a T-loop (Palm and de Lange, 
2008). We therefore speculate that the sequestration of ssDNA 
regions within 53BP1-OPT domains may provide a mechanism 
to prevent their repair by relatively error-prone gap-filling poly-
merases in G1 and allow progression into S phase, where such 
stretches of ssDNA could then be faithfully filled in by replica-
tive polymerases. Nevertheless, we are unable to exclude the 
possibility that, during the segregation of chromosomes during 
mitosis, unreplicated regions that are not resolved instead re-
sult in DNA DSBs. If this is the case, the persistence of OPT 
domains throughout G1 would imply that such DSBs are not 
repaired in G1, possibly because they require processing by 
factors that are not present in G1 or require modification by 
cyclin-dependent kinases as cells progress from G1 into S phase. 
Whatever the case, our data yield a model in which impaired 
DNA synthesis during S phase leads to activation of a DDR and 
the formation of 53BP1-OPT domains in the subsequent G1 in 
order to maintain genome integrity.
Materials and methods
Cell culture and treatments
Human BJ primary fibroblasts, BJ hTERT immortalized fibroblasts, and Seckel 
cells were cultured in DME (Invitrogen) supplemented with 15% FBS, penicillin, 
streptomycin, glutamine, and fungazone (PSQF). Human U2OS osteosarcoma 
cells and H2AX
/ and H2AX
+/+ MEFs (provided by A. Nussenzweig, Na-
tional Cancer Institute, National Institutes of Health, Bethesda, MD) were main-
tained  in  DME  plus  10%  FBS  and  PSQF.  U2OS  cells  stably  expressing 
pEGFP-53BP1 (Galanty et al., 2009) were grown in DME plus 10% FBS, 
PSQF, and G418 (500 µg/ml). U2OS cells stably expressing EGFP-53BP1 
and mRuby-PCNA (provided by P. Marco-Casanova, The Gurdon Institute, 
University of Cambridge, Cambridge, England, UK) were grown in DME plus 
10% FBS, PSQF, G418 (500 µg/ml), and 0.25 µg/ml puromycin.
Cells  were  incubated  with  APH  (Sigma-Aldrich)  or  HU  (Sigma- 
Aldrich) for 24 h as indicated. For inhibition of ATM, cells were incubated 
with the specific ATM inhibitor KU55933 (Hickson et al., 2004) at 20 µM 
for 3 h before fixation. To identify transcriptionally active regions, cells 
were incubated with 5 mM FlU (Sigma-Aldrich) for 60 min before fixation. 
Cells were irradiated using a Faxitron x-ray cabinet at 3.15 Gy/min.
Immunofluorescence microscopy
Cells were grown on glass coverslips and fixed with one of the following 
methods: ice-cold MeOH/acetone for 10 min at RT, 2% paraformaldehyde 
(PFA) for 15 min at RT followed by incubation with 0.5% Triton X-100 in 
PBS for 10 min at RT, 4% formaldehyde (FA; Sigma-Aldrich) in PBS for 15 min 
at RT followed by incubation with 0.5% Triton X-100 in PBS for 10 min at RT, 
or pre-extraction buffer (25 mM Hepes, pH 7.4, 50 mM NaCl, 1 mM 
EDTA, 3 mM MgCl2, 300 mM sucrose, and 0.5% Triton X-100) for 5 min at 
RT followed by fixation with 2% PFA for 15 min at RT. After fixation, cells were 
washed with PBS and blocked with either 5% FBS in PBS or 5% BSA in PBS. 
Cells were incubated with primary antibodies (1 h at RT or overnight at 4°C) 
in a marked increase in the mono-ubiquitylation of FANCD2, 
a well-characterized marker of replication stress (Howlett et al., 
2005). Thus, although exposure to both APH and HU partially 
inhibited  DNA  synthesis,  only APH  treatment  increased  the 
number of 53BP1-OPT domains in G1 cells. Collectively, our 
findings thereby indicated that 53BP1-OPT domains represent 
genomic loci that exhibit intrinsic replication difficulties, such 
as common fragile sites.
Discussion
We have established that 53BP1 is a new component of previously 
characterized OPT domains (Pombo et al., 1998), as it colocalizes 
with Oct-1 and PTF in large nuclear bodies of G1 cells. Consistent 
with what has been reported for OPT domains (Pombo et al., 1998), 
we found that 53BP1 nuclear bodies form early in G1 and then 
dissociate as cells enter and progress through S phase. Moreover, 
we show that localization of 53BP1 to OPT domains depends on 
H2AX and is largely abrogated by ATM inhibition, which, together 
with the colocalization of 53BP1-OPT domains with H2AX and 
MDC1, strongly suggests that these domains arise at sites of DNA 
damage. Although the presence of transcription factors Oct-1 and 
PTF in OPT domains has been taken as evidence that these repre-
sent sites of active transcription (Pombo et al., 1998), we find that 
53BP1-OPT domains are largely devoid of the phosphorylated, 
elongating forms of Pol II, and lack detectable transcription as as-
sessed by FlU labeling. These data are therefore in line with recent 
studies showing that DNA damage causes localized inhibition of 
transcription (Iacovoni et al., 2010; Shanbhag et al., 2010). In this 
regard, it is noteworthy that we have found that the RNA helicase 
DDX1 resides in 53BP1-OPT domains, and that this factor local-
izes to sites of DNA damage that do not contain newly synthesized 
RNA (Li et al., 2008). Collectively, our results therefore demon-
strate that OPT domains contain DNA damage signaling proteins 
and therefore likely mark sites of DNA damage.
In light of our data indicating that 53BP1-OPT domains 
are induced by APH and enriched at certain chromosomal frag-
ile sites, we suggest that 53BP1-OPT domains assemble on, and 
arise as a consequence of, sites of impaired replication from the 
previous S phase. Such incompletely replicated regions could 
arise through the actions of drugs such as APH, endogenously 
arising DNA damaging agents, or because of intrinsic replica-
tion difficulties at particular genomic loci. In this regard, it is 
noteworthy that recent work from Chan et al. (2009) has shown 
that APH treatment induces FANCD2 sister foci in metaphase 
chromosomes that colocalize with fragile site loci. Furthermore, 
10% of the FANCD2 sister foci observed in metaphase cells 
associate with Bloom syndrome helicase (BLM)-coated ultra-
fine bridges during anaphase (Chan et al., 2009). Collectively 
with these findings, our data suggest a model whereby certain 
regions of the genome, particularly those associated with chro-
mosomal fragile sites, may remain unreplicated during S phase. 
Such regions would then be bound by the Fanconi anemia pro-
teins FANCD2 and FANCI during G2 phase and upon entry into 
mitosis. During anaphase, BLM, together with topoisomerase IIIa 
and hRMI1, would then resolve the partially replicated, hemi-
catenated DNA (Chan et al., 2007), and upon entry into G1, 107 Replication stress induces 53BP1-OPT domains in G1 • Harrigan et al.
1% SDS, and 10 mM EDTA) and sonicated with a Bioruptor (Diagenode) at 
30-s intervals. ChIP was performed with rabbit IgG (Santa Cruz Biotechnology, 
Inc.) or rabbit anti-H2AX (07-164; Millipore) and Protein G–Sepharose 
beads (Sigma-Aldrich). DNA was eluted in a buffer containing 1% SDS and 
100 mM NaHCO3. After RNase and Proteinase K treatment, DNA was 
purified with a QIAquick PCR purification kit (QIAGEN). Libraries for ChIP-
seq were generated with a kit essentially as described by the manufacturer 
(Illumina, Inc.). Amplified DNA was run on 2% agarose gels and stained 
with SYBR green I (Invitrogen). Bands between 100 and 300 bp were ex-
cised, gel purified, and submitted to the Cambridge Research Institute (CRI) 
for sequencing. Resulting reads were mapped against the human genome 
(GRCh37) with bwa (Li and Durbin, 2009). Reads with bwa quality scores 
>13 were extended to the mean library length (200 bp). Resulting data were 
binned to 20-bp regions for display on the UCSC Genome Browser (Kent 
et al., 2002). Peaks were called using MACS 1.3.7 (Zhang et al., 2008) 
and HPeaks 1.1 (Qin et al., 2010) with IgG and H2AX as negative and 
positive controls, respectively. The intersection of overlapping peaks from 
both peak callers was used as a guide for visual inspection of the peaks. 
A final list of peaks was generated after the removal of false positives.
Flow cytometry
Cells were harvested by trypsinization, pelleted, resuspended in PBS, and 
fixed with cold 70% ethanol. The next day, cells were pelleted and resus-
pended in PBS containing 250 µg/ml RNase A and 10 µg/ml propidium 
iodide and incubated for 30 min at 37°C. Cells were analyzed with a 
FACSCalibur (Beckman Coulter) using CellQuest software.
Western immunoblotting
Cells were washed with PBS, scraped in Laemmli buffer (120 mM Tris, pH 6.8, 
4% SDS, and 20% glycerol), boiled for 5 min at 95°C, and syringed. Lysates 
were loaded on a 3–8% Tris-Acetate (Fig. 6 E) or 4–12% Tris-Glycine (Fig. S2 B)   
gel (Invitrogen), and proteins were transferred onto a polyvinylidene fluoride 
membrane. The membrane was blocked with 5% nonfat milk in TBS-T and 
incubated with primary antibodies for 1 h at RT. After washes with TBS-T, the 
membrane was incubated with the corresponding horseradish peroxidase–
conjugated secondary antibodies for 1 h at RT. Antigen–antibody complexes 
were  detected  by  enhanced  chemiluminescence  by  ECL  (GE  Healthcare).   
Antibodies used for Western blotting were: ATR (goat, N19; Santa Cruz Bio-
technology, Inc.), FANCD2 (mouse, FI17; Santa Cruz Biotechnology, Inc.), 
GRB2 (mouse; BD), or PARP-1 (rabbit, 9542; Cell Signaling Technology).
Online supplemental material
Fig. S1 shows that 53BP1 nuclear bodies do not colocalize with fibrillarin, 
coilin, or SC-35. Fig. S2 demonstrates that 53BP1-OPT domains form in ATR-
deficient Seckel cells. Fig. S3 demonstrates that Oct-1 and PTF localize to 
sites of DNA damage formed by laser micro-irradiation. Fig. S4 shows an 
increase in the number of PTF and PML bodies that colocalize with 53BP1 
after treatment of cells with a low dose of APH. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201011083/DC1.
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